RT

Ranjeet Tiwari

Director Director DIN 09376258
DIN 09376258 First appointment Oct 2021 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2021
Shareholding value Locked Premium profile

About Ranjeet Tiwari

Data last updated:

Ranjeet Tiwari has 4 years in corporate governance. Formerly with 1 company, such as Pulwin Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09376258
Primary Designation Director
First Appointment 20 Oct 2021
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Pulwin Pharma Private Limited U51909MH2017PTC302822
Additional Director20 Oct 20212017Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pulwin Pharma Private Limited
Premium access

Shareholding and investment profile for Ranjeet Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjeet Tiwari

Ranjeet Tiwari has 4 years in corporate governance. Formerly with 1 company, such as Pulwin Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Ranjeet Tiwari is associated with 0 companies as a director.

Ranjeet Tiwari has expertise in General Business.

Ranjeet Tiwari has 4 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available